Through research and clinical trials, we are working to improve current therapeutic approaches and outcomes for children with hematologic malignancies. We lead an internationally recognized clinical trials consortium for children and adolescents with newly diagnosed acute lymphoblastic leukemia - the DFCI ALL Consortium - consisting of 9 institutions in the United States and Canada. We are a founding member of a small national consortium of leading medical centers that investigate new treatments for children with Hodgkin lymphoma, including innovative drug combinations (and reduced exposure to radiation) that deliver results with fewer long-term complications. In addition, we participate in clinical trials conducted by the Histiocyte Society for patients with Langerhans Cell Histiocytosis.
To inquire about clinical trials, email us at firstname.lastname@example.org and read our clinical trial FAQ for answers to general questions.
Stay informed about our clinical trials research efforts. Sign up for our email newsletter Advances in Pediatric Hematology/Oncology.